Newest Phase 3 Cancer Drug Trials (2026)
As of November 2, 2026, “A Clinical Trial of Gocatamig (MK-6070) With Durvalumab in Participants With Small Cell Lung Cancer (MK-6070-004)” leads Newest Phase 3 Cancer Drug Trials with 2026-11-02. “Study of CM336+CM313 Combination Therapy in Patients With Relapsed or Refractory Multiple Myeloma” is second and “TRINITY TRIAL; Trial Of PRRT Plus CAPTEM Vs CAPTEM Alone In Well Differentiated GEP NETS” third.
Full ranking
How this ranking works
Phase 3 cancer drug trials that are recruiting or about to recruit, newest registrations first (ClinicalTrials.gov). A registered trial is not proof that a drug works. For information only, not medical advice.
Frequently asked questions
What is #1 in Newest Phase 3 Cancer Drug Trials?
As of November 2, 2026, #1 is “A Clinical Trial of Gocatamig (MK-6070) With Durvalumab in Participants With Small Cell Lung Cancer (MK-6070-004)”.
How is this ranking measured?
Phase 3 cancer drug trials that are recruiting or about to recruit, newest registrations first (ClinicalTrials.gov). A registered trial is not proof that a drug works. For information only, not medical advice.
How often is this chart updated?
Data is re-collected automatically and every page shows its last update date.
Can a brand pay to appear in this ranking?
No. There are no paid placements and no commercial influence on rank.
More rankings for you
🌍 Worldwide
Most Played PC Games Right Now
Dota 2•
PUBG: BATTLEGROUNDS•
Wallpaper Engine•Top Tech Stories Today
🌍 Worldwide
Trending Open-Source Projects This Week
heydamir/unslop▲1
anhao/ai-pose-gallery-zh▼1
wangzan101/Mika•